Oncology - Side Effects News & Articles

Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.

On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Patients 50+ may be at increased risk for pneumococcal disease. Learn what you can do.

Smartest Doc Challenge
MDLinx
Pediatric Oncology Clinical Pearls

D Scott Cunningham MD, PhD
Site Editor, MDLinx
Transition rates for adenomas to CRC

Jill Baker
MDLinx Career Center
New Jobs in Your Specialty

MDLinx Top Read
MDLinx
Are your journals collecting cobwebs?

MDLinx Conference Center
MDLinx
June Conference Calendar

New!	>> Find out who is the Smartest Doc in Oncology!

Articles

Latest (1) Full Text Articles (84) Focus on Hematology

Ranked, sorted, and summarized by MDLinx editors from the latest literature

Topics:

361 Prospective assessment of outcomes in 411 patients treated with hyperbaric oxygen for chronic radiation tissue injury Cancer, December 7, 2011 Clinical Article

362 Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer International Journal of Clinical Oncology, December 5, 2011

363 Adverse events after screening and follow-up colonoscopy Cancer Causes and Control, December 2, 2011

364 Anthracycline-related cardiomyopathy after childhood cancer: Role of polymorphisms in carbonyl reductase genes--a report from the childrens oncology group Full Text Journal of Clinical Oncology, December 1, 2011 Clinical Article

365 Clinical Presentation and Management of Hand–Foot Skin Reaction Associated with Sorafenib in Combination with Cytotoxic Chemotherapy: Experience in Breast Cancer Full Text The Oncologist, December 1, 2011 Clinical Article

366 Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer Journal of Infection, November 28, 2011

367 Prospective evaluation of incidence and severity of oral mucositis induced by conventional chemotherapy in solid tumors and malignant lymphomas Supportive Care in Cancer, November 28, 2011 Clinical Article

368 Aprepitant, dexamethasone, and palonosetron in the prevention of doxorubicin/cyclophosphamide-induced nausea and vomiting Supportive Care in Cancer, November 21, 2011

369 Severe clinical toxicities are correlated with survival in patients with advanced renal cell carcinoma treated with sunitinib and sorafenib British Journal of Cancer, November 21, 2011 Clinical Article

370 Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients Supportive Care in Cancer, November 21, 2011

371 Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs Full Text BMC Cancer, November 16, 2011

372 Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab Full Text Annals of Oncology, November 8, 2011 Clinical Article

373 Dermatologic side effects induced by new angiogenesis inhibitors Bulletin du Cancer, November 8, 2011

374 Rituximab induced myocardial infarction: A fatal drug reaction Journal of Cancer Research and Therapeutics, November 4, 2011

375 Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin European Journal of Cancer, November 2, 2011 Clinical Article

376 Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells Cancer Letters, October 31, 2011 Clinical Article

377 Topical silver sulfadiazine for the prevention of acute dermatitis during irradiation for breast cancer Supportive Care in Cancer, October 26, 2011 Clinical Article

378 Discontinuing Bevacizumab in Patients with Glioblastoma Full Text The Oncologist, October 24, 2011

379 Thyroid Dysfunction from Antineoplastic Agents Full Text Journal of the National Cancer Institute, October 20, 2011

380 Incidence, risk factors, and outcomes of osteonecrosis of the jaw: Integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases Full Text Annals of Oncology, October 17, 2011 Clinical Article

50 available pages First Previous 19 20 21 22 23 24 25 26 27 28 Next Last

Clinical Pearls in Oncology

The ZORO study demonstrated that the addition of goserelin to neoadjuvant chemotherapy for early breast cancer in premenopausal women resulted in no change in post-chemotherapy rates of amenorrhea
A little over 50% of tumors in women with ER-positive, node-negative breast cancers will have a RS <18, and current data suggests that these women are UNLIKELY to receive a benefit from adjuvant chemotherapy
In patients with completely resected ER-positive DCIS when the surgical specimen also has LCIS, consider breast MRI screening in addition to mammography due to the lower sensitivity of mammograms for lobular disease

» Test your knowledge. Take the Smartest Doc challenge today!

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.

Read the article summary

HCC risk increased in patients with AIDS

As reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.

Read the article summary

RAB25 is a prognostic marker for ovarian cancer

As reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Oncology Articles

Last month's top read Top Articles of 2012

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?

Oncology - Side Effects News & Articles

Articles

Clinical Pearls in Oncology

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

HCC risk increased in patients with AIDS

RAB25 is a prognostic marker for ovarian cancer

Most Popular Oncology Articles

Other Topics in Oncology